ASX:API - Australian Pharmaceutical Industries Stock Price, Forecast & News

Australian Pharmaceutical Industries' stock was trading at A$1.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, API stock has increased by 1.7% and is now trading at A$1.19. View which stocks have been mosted impacted by Coronavirus.

Australian Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Friday, April 17th 2020. View our earnings forecast for Australian Pharmaceutical Industries.

Australian Pharmaceutical Industries Ltd (ASX:API) posted its quarterly earnings results on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.05 by $0.00. View Australian Pharmaceutical Industries' earnings history.

Australian Pharmaceutical Industries announced a final dividend on Monday, October 28th. Stockholders of record on Thursday, December 12th will be paid a dividend of 0.04 per share on Thursday, December 12th. This represents a dividend yield of 2.93%. The ex-dividend date of this dividend is Wednesday, November 13th. View Australian Pharmaceutical Industries' dividend history.

News headlines about API stock have been trending very positive on Monday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Australian Pharmaceutical Industries earned a news sentiment score of 4.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutAustralian Pharmaceutical Industries.

Some companies that are related to Australian Pharmaceutical Industries include Electrocomponents (ECM), Finning International (FTT), Navitas (NVT), Hudson's Bay (HBC), First Majestic Silver (FR), Star Entertainment Group (SGR), Premier Investments (PMV), Diploma (DPLM), Nine Entertainment (NEC), Hays (HAS), Greggs (GRG), Fairfax Media (FXJ), Serco Group (SRP), SSP Group (SSPG) and G4S (GFS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Harvey Norman (HVN), Evolution Mining (EVN), Downer EDI (DOW) and Austal (ASB).

Australian Pharmaceutical Industries trades on the ASX under the ticker symbol "API."

One share of API stock can currently be purchased for approximately A$1.19.

Australian Pharmaceutical Industries has a market capitalization of $586.26 million and generates $4.01 billion in revenue each year.  View additional information about Australian Pharmaceutical Industries.

The official website for Australian Pharmaceutical Industries is http://www.api.net.au/.

Australian Pharmaceutical Industries' mailing address is L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia. The company can be reached via phone at +61-3-88553000.